Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792310205> ?p ?o ?g. }
- W2792310205 endingPage "e784" @default.
- W2792310205 startingPage "e777" @default.
- W2792310205 abstract "Several agents have demonstrated an overall survival (OS) benefit in patients with metastatic castration-resistant prostate cancer (mCRPC); however, the optimal sequencing of these therapies is unknown as a result of a lack of prospective randomized controlled trials. This retrospective study aimed to identify clinical factors influencing outcomes and to determine optimal treatment sequencing in patients with mCRPC treated with cabazitaxel (CABA) and/or androgen receptor-targeted agents (ART) after androgen-deprivation therapy (ADT) and docetaxel (DOC).Records of 574 consecutive patients treated (2012-2016) at 44 centers in 6 countries were retrospectively examined.A total of 267 patients received ADT → DOC → CABA (group 1), 183 patients ADT → DOC → ART → CABA (group 2), and 124 patients ADT → DOC → CABA → ART (group 3), with respective median OS from diagnosis of mCRPC of 38.3, 44.45, and 53.9 months (P = .012 for group 3 vs. group 1). Multivariate analysis showed response to first ADT ≤ 12 months, Gleason score of 8 to 10, clinical progression, and high prostate-specific antigen levels at mCRPC diagnosis were associated with worse OS. Prior receipt of ART did not influence activity of CABA.OS appeared to increase with the number of life-extending therapies, with a sequence including DOC, CABA, and an ART providing the greatest OS benefit." @default.
- W2792310205 created "2018-03-29" @default.
- W2792310205 creator A5001456598 @default.
- W2792310205 creator A5009585365 @default.
- W2792310205 creator A5023560654 @default.
- W2792310205 creator A5023874099 @default.
- W2792310205 creator A5024147987 @default.
- W2792310205 creator A5031237725 @default.
- W2792310205 creator A5041861170 @default.
- W2792310205 creator A5043891404 @default.
- W2792310205 creator A5047019507 @default.
- W2792310205 creator A5048494721 @default.
- W2792310205 creator A5050807694 @default.
- W2792310205 creator A5051297483 @default.
- W2792310205 creator A5063970223 @default.
- W2792310205 creator A5073752190 @default.
- W2792310205 creator A5073774746 @default.
- W2792310205 creator A5074756323 @default.
- W2792310205 creator A5078910130 @default.
- W2792310205 creator A5079820994 @default.
- W2792310205 creator A5084608959 @default.
- W2792310205 creator A5085695642 @default.
- W2792310205 creator A5089624043 @default.
- W2792310205 date "2018-08-01" @default.
- W2792310205 modified "2023-10-18" @default.
- W2792310205 title "Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor–Targeted Agents" @default.
- W2792310205 cites W1139515337 @default.
- W2792310205 cites W1969202480 @default.
- W2792310205 cites W1977645286 @default.
- W2792310205 cites W2036449946 @default.
- W2792310205 cites W2036601083 @default.
- W2792310205 cites W2064016579 @default.
- W2792310205 cites W2071879495 @default.
- W2792310205 cites W2123526148 @default.
- W2792310205 cites W2130669171 @default.
- W2792310205 cites W2137413455 @default.
- W2792310205 cites W2137467802 @default.
- W2792310205 cites W2141454098 @default.
- W2792310205 cites W2142466432 @default.
- W2792310205 cites W2150865892 @default.
- W2792310205 cites W2154368013 @default.
- W2792310205 cites W2163144362 @default.
- W2792310205 cites W2164884291 @default.
- W2792310205 cites W2166918329 @default.
- W2792310205 cites W2187005893 @default.
- W2792310205 cites W2214621962 @default.
- W2792310205 cites W2221430323 @default.
- W2792310205 cites W2511755939 @default.
- W2792310205 cites W2620746860 @default.
- W2792310205 cites W2620798309 @default.
- W2792310205 cites W2740979023 @default.
- W2792310205 cites W962578561 @default.
- W2792310205 doi "https://doi.org/10.1016/j.clgc.2018.02.016" @default.
- W2792310205 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29550200" @default.
- W2792310205 hasPublicationYear "2018" @default.
- W2792310205 type Work @default.
- W2792310205 sameAs 2792310205 @default.
- W2792310205 citedByCount "20" @default.
- W2792310205 countsByYear W27923102052019 @default.
- W2792310205 countsByYear W27923102052020 @default.
- W2792310205 countsByYear W27923102052021 @default.
- W2792310205 countsByYear W27923102052022 @default.
- W2792310205 countsByYear W27923102052023 @default.
- W2792310205 crossrefType "journal-article" @default.
- W2792310205 hasAuthorship W2792310205A5001456598 @default.
- W2792310205 hasAuthorship W2792310205A5009585365 @default.
- W2792310205 hasAuthorship W2792310205A5023560654 @default.
- W2792310205 hasAuthorship W2792310205A5023874099 @default.
- W2792310205 hasAuthorship W2792310205A5024147987 @default.
- W2792310205 hasAuthorship W2792310205A5031237725 @default.
- W2792310205 hasAuthorship W2792310205A5041861170 @default.
- W2792310205 hasAuthorship W2792310205A5043891404 @default.
- W2792310205 hasAuthorship W2792310205A5047019507 @default.
- W2792310205 hasAuthorship W2792310205A5048494721 @default.
- W2792310205 hasAuthorship W2792310205A5050807694 @default.
- W2792310205 hasAuthorship W2792310205A5051297483 @default.
- W2792310205 hasAuthorship W2792310205A5063970223 @default.
- W2792310205 hasAuthorship W2792310205A5073752190 @default.
- W2792310205 hasAuthorship W2792310205A5073774746 @default.
- W2792310205 hasAuthorship W2792310205A5074756323 @default.
- W2792310205 hasAuthorship W2792310205A5078910130 @default.
- W2792310205 hasAuthorship W2792310205A5079820994 @default.
- W2792310205 hasAuthorship W2792310205A5084608959 @default.
- W2792310205 hasAuthorship W2792310205A5085695642 @default.
- W2792310205 hasAuthorship W2792310205A5089624043 @default.
- W2792310205 hasConcept C121608353 @default.
- W2792310205 hasConcept C126322002 @default.
- W2792310205 hasConcept C143998085 @default.
- W2792310205 hasConcept C2776551883 @default.
- W2792310205 hasConcept C2777899217 @default.
- W2792310205 hasConcept C2778971682 @default.
- W2792310205 hasConcept C2780192828 @default.
- W2792310205 hasConcept C2781190966 @default.
- W2792310205 hasConcept C535046627 @default.
- W2792310205 hasConcept C61367390 @default.
- W2792310205 hasConcept C71924100 @default.
- W2792310205 hasConceptScore W2792310205C121608353 @default.
- W2792310205 hasConceptScore W2792310205C126322002 @default.